ACCELLENA continues to strengthen its international presence with the opening of its first Asiatic office in Beijing as part of a business trip to China. The new office is headed by Master of Science Li Wen.
The highlight of the trip was ACCELLENA's participation in one of the largest industry exhibitions – BIOCHINA. During the event, the company's representatives held negotiations with leading pharmaceutical and biotechnology businesses of China and South Korea, discussing prospects for cooperation in the fields of biomedicine and clinical research.
One of the key moments of ACCELLENA's participation in BIOCHINA was the speech by the company's Founder and Medical Director Konstantin Zakharov at the panel discussion titled "Exploring Opportunities for China-Russia Cooperation in Biologics Technology Development, Technology Transfer, and Upstream Supply Chain." The session was moderated by Wei Liu, Secretary-General of the Russian Institute, Tsinghua University.
BIOCHINA's program included not only discussion platforms but also ample opportunities for business meetings and knowledge exchange. During an interview with one of China’s leading television channels, ACCELLENA’s Business Development Director Anna Lineva presented the company’s key services and shared its strategic plans for the Chinese market.
"Russia-China cooperation in biomedicine is becoming increasingly significant. We witness the ongoing expansion of dialogue between our countries each year, opening new horizons for joint initiatives. Participating in BIOCHINA has been an important step in strengthening these ties, and we are confident that this is only the beginning of a long journey toward building sustainable international projects," noted Anna Lineva.
As part of the trip, ACCELLENA’s delegation also visited Shanghai to expand cooperation with scientific organizations, opening additional prospects for international projects.
The trip to China was a significant milestone for the company, unlocking new opportunities for strengthening international partnerships and implementing joint initiatives in biomedicine, clinical research, and microbiology.
The highlight of the trip was ACCELLENA's participation in one of the largest industry exhibitions – BIOCHINA. During the event, the company's representatives held negotiations with leading pharmaceutical and biotechnology businesses of China and South Korea, discussing prospects for cooperation in the fields of biomedicine and clinical research.
One of the key moments of ACCELLENA's participation in BIOCHINA was the speech by the company's Founder and Medical Director Konstantin Zakharov at the panel discussion titled "Exploring Opportunities for China-Russia Cooperation in Biologics Technology Development, Technology Transfer, and Upstream Supply Chain." The session was moderated by Wei Liu, Secretary-General of the Russian Institute, Tsinghua University.
BIOCHINA's program included not only discussion platforms but also ample opportunities for business meetings and knowledge exchange. During an interview with one of China’s leading television channels, ACCELLENA’s Business Development Director Anna Lineva presented the company’s key services and shared its strategic plans for the Chinese market.
"Russia-China cooperation in biomedicine is becoming increasingly significant. We witness the ongoing expansion of dialogue between our countries each year, opening new horizons for joint initiatives. Participating in BIOCHINA has been an important step in strengthening these ties, and we are confident that this is only the beginning of a long journey toward building sustainable international projects," noted Anna Lineva.
As part of the trip, ACCELLENA’s delegation also visited Shanghai to expand cooperation with scientific organizations, opening additional prospects for international projects.
The trip to China was a significant milestone for the company, unlocking new opportunities for strengthening international partnerships and implementing joint initiatives in biomedicine, clinical research, and microbiology.
